Smoking and lung function of Lung Health Study participants after 11 years.
By N. Anthonisen, J. Connett, R. Murray. American Journal of Respiratory and Critical Care Medicine, 2002
741 citations recorded by the source corpus.
Subfields: Health, Toxicology and Mutagenesis, Physiology, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/30995024875b7d56ffdf8c3d44c3f5133d6ad469
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Physiology
In Pulmonary and Respiratory Medicine
Citations in the corpus
- Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. (2008, methodology): “Female patients lost FEV1 at a slower rate than that of male patients, a result similar to that reported in the long-term follow-up of the Lung Health Study ( 4 ).”
- Developing COPD: a 25 year follow up study of the general population (2006, background): “21 Moreover, the beneficial effect of smoking cessation is not limited to COPD, not even in patients with COPD.”
- The Effects of a Smoking Cessation Intervention on 14.5-Year Mortality (2005, positive): “We have shown that smoking status established at 5 years changed relatively little in the next 6 years, especially among sustained quitters (6).”
- The overlap syndrome of asthma and COPD: what are its features and how important is it? (2009, background): “30”
- Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution (2023, neutral): “Несмотря на то что в нескольких продольных исследова ниях ХОБЛ проводилось длительное (до 20 лет) наблю дение за группами пациентов и населением [25], ни в одном из этих исследований не отслеживали течение за болевания от начала до конца и не наблюдали за пациен тами в пре и перинатальном периодах, ”